Research Services PMR

Cancer treatment approach in the Czech Republic, Russia and Slovakia

  • Industry

    Metastatic renal cell carcinoma treatment

  • Geographical coverage

    Czech Republic, Russia, Slovakia

  • Client type

    Market research agency

  • Delivery time

    5 weeks

Research Project - medical and pharmaceutical market

Client's need

Metastatic renal cell carcinoma (mRCC), also known as renal cell cancer or renal cell adenocarcinoma, is by far the most common type of kidney cancer. Our client was interested in investigating potential uptake of a new product in emerging markets. The purpose of this research was to discuss physicians’ treatment approach in metastatic renal cell carcinoma and the different types of patients they are visited by.

Our deliverables

We have conducted a series of in-depth interviews (IDIs) with oncologists who manage patients with mRCC in Slovakia, Czech Republic and Russia. All interviews were conducted face to face in specialists’ offices. During IDIs we have reviewed prescribing sequencing and discussed different patient types and treatment decision making criterion across each line of therapy.

Value for the client

Research results allowed us to understand what drives physicians in mRCC therapies, with a view to understanding the current situation in preparation for the launch of client’s new products.

Back to List of Projects - Research PMR